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C3 ADP-ribosyltransferase (C3), derived from Clostrid-1School of Biosciences
ium botulinum, irreversibly inactivates all three isoformsUniversity of Birmingham
of Rho (RhoA, -B, and -C) [4]. It has previously beenEdgbaston, Birmingham B15 2TT
reported that EDIN, a Staphylococcus aureus homologUnited Kingdom
of C3, inhibits keratinocyte differentiation [5]. We asked2 Keratinocyte Laboratory
whether inhibiting Rho function by using C3 affectedCancer Research UK
keratinocyte terminal differentiation by placing keratino-44 Lincoln’s Inn Fields
cytes in single-cell suspension for 24 hr in the presenceLondon WC2A 3PX
or absence of recombinant C3. Treatment of differentiat-United Kingdom
ing cells with 5 g ml1 C3 resulted in a statistically3 GlaxoSmithKline Pharmaceuticals
significant (p  0.001) decrease in the number of cellsNew Frontiers Science Park
expressing Involucrin, a marker for keratinocyte differ-Third Avenue
entiation (Figure 1A) [6]. We observed a similar decreaseHarlow CM19 5AW
when we used Transglutaminase-1 as an alternativeUnited Kingdom
marker for keratinocyte differentiation (Figure 1B) [6].4 Abramson Family Cancer Research Institute
Having observed regulation of keratinocyte differentia-University of Pennsylvania
tion by C3, we analyzed whether patterns of RhoA ex-BRB II/III, 421 Curie Boulevard
pression and activity changed during keratinocyte dif-Philadelphia, Pennsylvania 19104
ferentiation. No change in expression of RhoA was
observed when keratinocytes were induced to undergo
terminal differentiation by culture in single-cell suspen-
sion (Figure 1C). Similarly, using an in vitro assay inSummary
which the Rho binding domain of Rhotekin was used to
pulldown Rho in its active GTP bound form, we observedThe epidermis comprises multiple layers of special-
no significant difference in RhoA activity during the dif-ized epithelial cells called keratinocytes. As cells are
ferentiation process (Figure 1D). This is in contrast to alost from the outermost epidermal layers, they are
recent study that reported increased Rho activity duringreplaced through terminal differentiation, in which ker-
calcium-induced keratinocyte differentiation [7]. Theatinocytes of the basal layer cease proliferating, mi-
reasons for this discrepancy are not clear but may reflectgrate upwards, and eventually reach the outermost
differing experimental conditions.cornified layers. Normal homeostasis of the epidermis
One of the principal downstream effectors of Rho isrequires that the balance between proliferation and
the serine/threonine kinase, ROCK. Both isoforms ofdifferentiation be tightly regulated [1]. The GTP binding
ROCK are expressed in keratinocytes, but the predomi-protein RhoA plays a fundamental role in the regulation
nant isoform is ROCK-II (data not shown). To indirectlyof the actin cytoskeleton and in the adhesion events
analyze ROCK activity during suspension-induced kera-that are critically important to normal tissue homeo-
tinocyte differentiation, we used a phospho-specific an-stasis [2]. Two central mediators of the signals from
tibody against Myosin Phosphatase Target Subunit 1RhoA are the ROCK serine/threonine kinases ROCK-I
(MYPT1), a known substrate of ROCK [8]. Although ex-and ROCK-II [3]. We have analyzed ROCK’s role in the
pression of ROCK-II did not significantly change duringregulation of epidermal keratinocyte function by using
keratinocyte differentiation, a significant increase ina pharmacological inhibitor and expressing condition-
phosphorylation of MYPT1 was observed (Figure 1E).ally active or inactive forms of ROCK-II in primary hu-
To analyze further the role of ROCK, we used Y-27632,man keratinocytes. We report that blocking ROCK
a pharmacological inhibitor of ROCK [9]. Cells werefunction results in inhibition of keratinocyte terminal
placed in suspension in the presence of increasing con-differentiation and an increase in cell proliferation. In
centrations of Y-27632 for 12 hr, and differentiation wascontrast, activation of ROCK-II in keratinocytes results
assessed by analysis of Involucrin expression. Statisti-in cell cycle arrest and an increase in the expression
cally significant (p  0.05) inhibition of differentiationof a number of genes associated with terminal differ-
was observed in the presence of 1 M Y-27632, withentiation. Thus, these results indicate that ROCK plays
almost complete inhibition in the presence of 5 M ora critical role in regulating the balance between prolif-
10 M Y-27632 (Figure 1F). No evidence of increasederation and differentiation in human keratinocytes.
cell death was observed (data not shown). These data
are consistent with ROCK acting downstream of RhoA
to regulate keratinocyte differentiation.*Correspondence: n.a.hotchin@bham.ac.uk
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Figure 1. ROCK Acts Downstream of Rho to
Regulate Keratinocyte Differentiation
(A and B) To induce terminal differentiation,
we placed cells in single-cell suspension in
the presence or absence of 5 g/ml C3 for
24 hr. After harvesting, cells were immuno-
stained with antibodies against Involucrin (A)
or Transglutaminase-1 (TGM-1) (B), and the
percentage of positive cells was calculated.
(C) Cell lysates were prepared from adherent,
preconfluent keratinocytes, and cells were in-
duced to differentiate by being placed in sin-
gle-cell suspension for 24 hr. Expression of
involucrin and RhoA was detected by West-
ern blotting. (D) The Rho binding domain of
Rhotekin was used for precipitating GTP
bound active RhoA from cell lysates. The GTP
bound RhoA was then detected with RhoA-
specific antibodies after SDS-PAGE and
Western blotting. As controls, total cell ly-
sates were also prepared and Western blot-
ted with an antibody to RhoA. (E) Cell lysates
were prepared from adherent, preconfluent
keratinocytes, and cells were induced to dif-
ferentiate by placement in single-cell suspen-
sion for 24 hr. Expression of ROCK-II and
phospho-MYPT1 was detected by Western
blotting with specific antibodies. (F) The ef-
fect of ROCK inhibition on keratinocyte differ-
entiation was assessed via placement of cells
in suspension in the presence of increasing
concentrations (1–10 M) of the pharmaco-
logical inhibitor Y-27632 for 12 hr. After har-
vesting, cells were immunostained and invo-
lucrin-positive cells were counted. Results
from (A), (B), and (F) are the mean and stan-
dard error of three separate experiments, and
statistical comparisons were made via the
Student’s T-test (* p  0.05; ** p  0.001).
Inhibition of ROCK Results in Increased nies present after 14 days of culture in the presence of
Y-27632 (Figure 2B). Thus, we observed that inactivationKeratinocyte Proliferation
Having observed that pharmacological inhibition of of ROCK resulted both in inhibition of keratinocyte termi-
nal differentiation and in a increase in proliferative ca-ROCK significantly inhibited keratinocyte differentiation,
we analyzed cell cycle progression by examining the pacity. Although it is not possible to establish the exact
timing of events, this clearly suggests that ROCK playsincorporation of the nucleoside analog bromodeoxyuri-
dine (BrdU) into nascent DNA. Subconfluent keratino- a key role in determining keratinocyte fate. In some cell
types there is evidence that Rho and Rac act antagonis-cytes were incubated in BrdU-labeling medium in the
presence or absence of 5 M Y-27632 for 1, 8, 12, and tically and that Rac1 activity is required for cell cycle
progression [10–12]. Thus, the possibility existed that16 hr and then immunostained with an antibody against
BrdU. After 12 hr of Y-27632 treatment, a statistically ROCK inhibition might result in altered Rac1 activity and
that this might contribute to the observed increase insignificant increase (p  0.001) in the number of BrdU-
positive cells was observed in treated versus untreated proliferation. However, pulldown assays that utilized the
ability of the Rac binding domain of PAK1 to associatecontrol cells (Figure 2A). The increased proportion of S
phase cells suggested that inhibition of ROCK might with active GTP bound but not inactive GDP bound Rac1
revealed no difference in Rac1 activity in cells treatedincrease the proliferative capacity of these cells. To ana-
lyze this, we determined the colony-forming efficiencies with Y-27632 (Figure 2C). Thus, it is unlikely that the
inhibition of differentiation and increase in proliferationof keratinocytes cultured in the presence or absence of
5 M Y-27632. We observed a statistically significant we observed were a consequence of altered Rac1 ac-
tivity.increase (p  0.05) in the number of keratinocyte colo-
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Activation of ROCK-II Results in Cell Cycle Arrest
and Increased Expression of Involucrin
To analyze further the role of ROCK in regulating kera-
tinocyte function, retroviral transduction was used to
establish primary human keratinocytes stably express-
ing a chimeric protein consisting of the catalytic domain
of ROCK-II fused at the carboxy-terminal end to a mu-
tated ligand binding domain of the estrogen receptor
(ER) and to enhanced green fluorescence protein at the
amino terminus (D.R.C. and M.F.O., unpublished data).
The ROCK:ER fusion protein is constitutively expressed
but is inactive because of the binding of a heat shock
protein (HSP90) to the ER ligand binding domain [13].
Addition of the estrogen homolog, 4-hydroxytamoxifen
(4-HT), results in displacement of HSP90 and activation
of the kinase. In addition, cell lines stably expressing a
kinase-dead form of ROCK-II (KD ROCK:ER) were estab-
lished. To analyze ROCK-II activity, we performed in
vitro kinase assays in which we assessed the ability of
immunoprecipitated ROCK-II to phosphorylate Histone
H1. ROCK-II activity was induced 7-fold by 4-HT in ly-
sates prepared from ROCK:ER cells (Figure 3A), whereas
no significant ROCK activity was observed in the ab-
sence or presence of 4-HT in the KD ROCK:ER control
lysates (Figure 3A). We saw no evidence that 4-HT af-
fected expression of ROCK-II (Figure 3B).
Having observed that Y-27632 treatment resulted in
increased keratinocyte cell cycle progression (Figure 2),
we analyzed BrdU incorporation in keratinocytes ex-
pressing ROCK:ER in the presence or absence of 4-HT.
Significant (p  0.001) inhibition of BrdU incorporation
was observed in ROCK:ER-expressing cells after treat-
ment with 4-HT compared to no 4-HT (Figure 3C). No
inhibition of cell cycle progression was observed in cells
expressing the kinase-dead form of ROCK-II when they
were treated with 4-HT (data not shown). Previous work
has indicated that RhoA is required for cell cycle pro-
gression in Swiss 3T3 fibroblasts [10]. The observation
that, in primary keratinocytes, activation of ROCK-II re-
sults in cell cycle arrest is novel and suggests that the
role of Rho signaling in cell cycle progression may be
cell-type specific.
Figure 2. Inhibition of ROCK Results in Increased Cell Cycle Pro- We next analyzed the effect of activating ROCK-II on
gression without Altering Rac Activity keratinocyte differentiation. We induced keratinocytes
(A) Cells were incubated with BrdU and 5 M Y-27632 for 1, 8, expressing ROCK:ER to undergo terminal differentiation
12, and 16 hr. Cells incorporating BrdU were detected by indirect
by placing cells in suspension, in the presence or ab-immunofluorescence. Data presented are the mean and standard
sence of 100 nM 4-HT, for 24 hr. No inhibition of differen-error of three separate experiments, and statistical significance was
tiation was observed after activation of ROCK-II. (Figuredetermined via a Student’s T-test (*p 0.05; **p 0.001) (B). Prolif-
erative capacity in the presence or absence of Y-27632 was as- 1, Supplemental Data). Having observed that activation
sessed from colony-forming efficiency. Keratinocytes were seeded of ROCK-II did not affect the ability of cells to undergo
at low density and cultured in the presence or absence of 5 M differentiation when in suspension, we analyzed expres-
Y-27632 for 14 days. After this time, cells were fixed, stained with
sion of Involucrin in adherent keratinocytes expressing1% rhodanile blue, and the number of colonies was counted. Data
KD ROCK:ER and ROCK:ER in the presence or absenceare the mean and standard error from three separate experiments
(*p  0.05). (C) For the analysis of Rac activity, cells were treated of 4-HT. In the presence of 4-HT, we observed a statisti-
with 5 M Y-27632 for 0, 1, 4, 8, and 12 hr and lysed, and the Rac cally significant increase (p  0.05) in the numbers of
binding domain of PAK was used for precipitation of GTP bound adherent ROCK:ER cells expressing Involucrin but no
active Rac from lysates. GTP-Rac was subsequently detected via
increase in numbers of Involucrin-positive KD ROCK:ERSDS-PAGE and Western blotting.
cells (Figure 3D). Thus, these data indicate that ROCK
is involved not only in the regulation of suspension-
induced differentiation but also in the initiation of differ-
entiation in adherent keratinocytes.
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Figure 3. Activation of ROCK-II Inhibits Cell
Cycle Progression and Increases Expression
of Involucrin in Normal Adherent Keratino-
cytes
(A) The activity of exogenous ROCK-II was
assessed via an in vitro kinase assay in which
the ability of immunoprecipitated ROCK-II to
phosphorylate an artificial substrate, Histone
H1, was measured. Cells expressing kinase-
dead ROCK-II (KD ROCK) or active ROCK-II
(ROCK) were incubated in the presence or
absence of 100 nM 4-HT for 12 hr and lysed,
and the kinase assay was performed. (B) Cells
expressing active ROCK-II were cultured in
the presence of 100 nM 4-HT for up to 48 h,
and protein lysates were prepared. Expres-
sion of ROCK-II was determined by Western
blotting. (C) Cell cycle progression after acti-
vation of ROCK was assessed via BrdU incor-
poration during DNA synthesis. Cells ex-
pressing ROCK:ER were incubated in the
presence or absence of 100 nM 4-HT for 12
hr and then BrdU labeled for 1 hr. The number
of BrdU-positive cells was determined by in-
direct immunofluorescence, and data pre-
sented are the mean and standard error of
three separate experiments. Statistical analy-
sis was performed via the Student’s T-test
(**p  0.001). (D) Adherent keratinocytes ex-
pressing wild-type ROCK-II (ROCK) or the ki-
nase-dead form of ROCK-II (KD ROCK) were
incubated in the absence or presence of 100
nM 4-HT for 12 hr and then immunostained
for the differentiation marker involucrin. Num-
bers of involucrin-positive cells were counted,
and results were expressed relative to cells
cultured in the absence of 4-HT. Data are the
mean and standard error of three sep-
arate experiments. Statistical analysis was performed via the Student’s T-test (*p  0.05). (E) Protein lysates were prepared from adherent
keratinocytes that expressed the conditionally active form of ROCK (ROCK:ER) and had been cultured in the presence of 100 nM 4-HT for 0,
24, and 48 hr. Expression of Involucrin, Desmocollin-1, Desmocollin-2, and E-Cadherin was determined by Western blotting.
Activation of ROCK-II in Human Keratinocytes to analyze gene expression after activation of ROCK-II.
Initially, as a control, we analyzed the gene expressionInduces Expression of a Number
of Differentiation Markers profile of keratinocytes expressing the kinase-dead form
of ROCK-II (KD ROCK:ER) in the presence or absenceTo determine further the role of ROCK-II in regulating
keratinocyte function, we used Affymetrix gene arrays of 4-HT. Analysis of data from this experiment revealed
Table 1. Differentiation-Related Genes Upregulated More than 2-Fold upon Activation of ROCK-II
Description Gene CE EDC Reference
Involucrin IVL   [6]
Keratin 1 KRT1   [6]
Keratin 10 KRT10   [6]
Desmocollin 1 DSC1   [15]
Desmocollin 2 DSC2   [15]
Desmoglein 1 DSG1   [16]
Desmoglein 3 DSG3   [16]
Desmoplakin I/II DPI/DPII   [6]
Serine protease inhibitor kazal type 5 SPINK5   [19]
Elafin PI3   [6]
Fatty acid binding protein 5 FABP5   [20]
Small proline-rich protein 3 SPRR3   [6]
Psoriasin 1 S100A7   [6]
Calgranulin A S100A8   [6]
Sciellin SCEL   [14]
Periplakin PPL   [6]
CE indicates genes encoding proteins involved in formation of the epidermal cornified envelope. EDC indicates genes clustered in the Epidermal
Differentiation Complex located on chromosome 1q21.
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